H. B. Fuller (NYSE:FUL) Announces Earnings Results, Beats Estimates By $0.04 EPS

Posted by Brenda Bartman on Jun 24th, 2026

H. B. Fuller (NYSE:FUL – Get Free Report) announced its quarterly earnings data on Wednesday. The specialty chemicals company reported $1.41 earnings per share for the quarter, topping analysts’ consensus estimates of $1.37 by $0.04, Zacks reports. H. B. Fuller had a return on equity of 11.84% and a net margin of 4.62%. H. B. Fuller updated its FY 2026 guidance to 4.600-4.900 EPS.

H. B. Fuller Price Performance

FUL stock traded up $1.36 on Wednesday, reaching $64.48. The company had a trading volume of 1,121,212 shares, compared to its average volume of 594,637. The company has a debt-to-equity ratio of 1.01, a quick ratio of 1.15 and a current ratio of 1.92. The company’s fifty day moving average is $61.62 and its 200 day moving average is $61.21. The company has a market cap of $3.51 billion, a P/E ratio of 21.28, a PEG ratio of 0.84 and a beta of 0.96. H. B. Fuller has a 1 year low of $48.71 and a 1 year high of $68.63.

H. B. Fuller Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, May 14th. Stockholders of record on Thursday, April 30th were paid a dividend of $0.245 per share. This is a positive change from H. B. Fuller’s previous quarterly dividend of $0.23. The ex-dividend date of this dividend was Thursday, April 30th. This represents a $0.98 dividend on an annualized basis and a dividend yield of 1.5%. H. B. Fuller’s dividend payout ratio is 32.34%.

Analyst Upgrades and Downgrades

Several brokerages have commented on FUL. Wall Street Zen upgraded shares of H. B. Fuller from a “hold” rating to a “buy” rating in a research report on Sunday, March 29th. JPMorgan Chase & Co. raised shares of H. B. Fuller from an “underweight” rating to a “neutral” rating and set a $58.00 target price for the company in a report on Wednesday, May 27th. UBS Group raised their price objective on H. B. Fuller from $63.00 to $71.00 and gave the company a “neutral” rating in a research note on Wednesday, June 17th. Royal Bank Of Canada set a $58.00 price objective on H. B. Fuller in a report on Wednesday, May 27th. Finally, Vertical Research upgraded H. B. Fuller from a “hold” rating to a “strong-buy” rating in a research report on Friday, March 27th. One analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $66.40.

Read Our Latest Report on FUL

Insider Transactions at H. B. Fuller

In other news, CEO Celeste Beeks Mastin purchased 5,170 shares of the firm’s stock in a transaction on Tuesday, April 7th. The shares were bought at an average cost of $57.08 per share, with a total value of $295,103.60. Following the purchase, the chief executive officer directly owned 8,670 shares of the company’s stock, valued at approximately $494,883.60. This trade represents a 147.71% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 1.83% of the company’s stock.

Institutional Trading of H. B. Fuller

A number of hedge funds have recently bought and sold shares of FUL. Strs Ohio acquired a new position in H. B. Fuller in the 1st quarter valued at $101,000. EverSource Wealth Advisors LLC boosted its holdings in shares of H. B. Fuller by 129.8% during the second quarter. EverSource Wealth Advisors LLC now owns 1,218 shares of the specialty chemicals company’s stock worth $73,000 after purchasing an additional 688 shares during the last quarter. Baird Financial Group Inc. boosted its holdings in shares of H. B. Fuller by 19.6% during the second quarter. Baird Financial Group Inc. now owns 7,518 shares of the specialty chemicals company’s stock worth $452,000 after purchasing an additional 1,232 shares during the last quarter. Marshall Wace LLP grew its position in shares of H. B. Fuller by 382.1% in the second quarter. Marshall Wace LLP now owns 20,370 shares of the specialty chemicals company’s stock valued at $1,225,000 after purchasing an additional 16,145 shares during the period. Finally, Cerity Partners LLC increased its stake in H. B. Fuller by 2.3% in the second quarter. Cerity Partners LLC now owns 11,499 shares of the specialty chemicals company’s stock valued at $692,000 after purchasing an additional 261 shares during the last quarter. Institutional investors and hedge funds own 95.93% of the company’s stock.

H. B. Fuller Company Profile

(Get Free Report)

H. B. Fuller Company, founded in 1887 and headquartered in St. Paul, Minnesota, is a global adhesives and specialty chemical solutions provider serving a wide array of industries. The company develops, manufactures and markets adhesive technologies, sealants, polymers and related chemical products designed to enhance product performance, sustainability and manufacturing efficiency.

Fuller’s product portfolio spans multiple market segments, including packaging and converting, general industrial assembly, electronics, transportation, hygiene and construction.